Nelson Sun insider trades

Open-market stock purchases and sales by Nelson Sun, Chief Financial Officer at Aardvark Therapeutics, Inc, from SEC Form 4 filings since Feb 14, 2025.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -70%.

Recent trades

DateStockTradeValue
Feb 9, 2026AARD Aardvark Therapeutics, IncSold (not open market)—
Dec 11, 2025AARD Aardvark Therapeutics, IncBought$43.2K

Companies traded

  • AARD Aardvark Therapeutics, Inc: 3 buys, last Feb 9, 2026

Get free alerts when Nelson Sun files a new trade →